What research gaps exist regarding the pharmacodynamics of cannabinoids in different populations?
What research gaps exist regarding the pharmacodynamics of cannabinoids in different populations? Research gaps regarding the pharmacodynamics of cannabinoids in different populations include limited understanding of how factors such as age, sex, genetics, and comorbidities influence cannabinoid effects and metabolism. There is a need for more studies that explore these variations, as current research often focuses on homogenous populations, limiting generalizability. Additionally, understanding how socio-economic and cultural factors affect cannabinoid use and responses is essential for developing inclusive research strategies. Further exploration into the pharmacodynamics of cannabinoids across diverse populations can provide insights that improve treatment efficacy and safety. Addressing these gaps is crucial for advancing cannabinoid research and ensuring equitable access to therapies (Wilkinson et al., 2020).